EDTUTC-4 New YorkLog in Sign up

NVO
Novo-Nordisk A/S
stockNYSEADR

At CloseOct 27, 2026 3:59:59 PM EDT

38.67USD-1.176%(-0.46)6,775,935

Pre-marketOct 27, 2026 9:29:59 AM EDT

38.58USD-1.406%(-0.55)

After-hoursOct 27, 2026 4:57:30 PM EDT

38.69USD+0.052%(+0.02)

Loading…

Loading…

170.78B

Healthcare

Biotechnology

HQ

Bagsvaerd, Bagsvaerd, Denmark

57,089

Previous Close

$39.13

Beta

1.02

52-Week High

$64.16 2026-01-23

52-Week Low

$35.12 2026-03-30

SMA 50

$41.65

SMA 200

$44.50

Avg. Vol 10D

9.12M

Avg. Vol 30D

13.31M

Avg. Vol 90D

12.12M

Relative Vol

0.51

4.41B

3.17B

71.92%

37,436,108

Short Interest %

1.18%

3.11

On/Off Exchange

54%/46%

58.76%

Short Vol % (off-exch)

38.94%

0.3700%

10,000,000

192

7,421

22,844

Nov 4, 2026 (7d)

Mar 31, 2025 · $1.099

Sep 20, 2023 · 2-for-1

Oct 27, 2026

11:10 AM EDTAmgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026? ·

The Motley Fool

07:30 AM EDTJudge denied Novo Nordisk bid to block Eli Lilly weight-loss drug ads ·

Quartz

06:04 AM EDTHengrui Pharma Reports Steady Growth in the First Nine Months of 2026 ·

PR Newswire

03:10 AM EDTEli Lilly defeats Novo Nordisk attempt to halt weight-loss drug ads ·

Seeking Alpha

Oct 26, 2026

06:30 PM EDTUS judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk ·

Reuters

NVO Profile

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.

NVO Performance

Period	Price	Date	Change	Beta
1W	39.06	2026-10-21	-0.90%	-0.506
3M	50.96	2026-07-28	-24.04%	-0.363
6M	41.17	2026-04-28	-5.97%	0.015
1Y	52.05	2025-10-28	-25.63%	1.017
2Y	112.36	2024-10-28	-65.55%	—
5Y	53.83	2021-10-28	-28.08%	0.669

NVO Stock Summary

Novo-Nordisk A/S (NYSE:NVO) stock price today is $38.71, and today's volume is 6,775,935. NVO is down 1.073% today. The 30 day average volume is 13.31M. NVO market cap is $170.78B with 4.41B shares outstanding.